Analystreport

VBI Vaccines Inc (NASDAQ: VBIV) was given a new $5.00 price target on by analysts at Oppenheimer Holdings Inc.. They now have a "buy" rating on the stock.

VBI Vaccines, Inc. - Ordinary Shares  (VBIV) 
Last vbi vaccines, inc. - ordinary shares earnings: 11/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: vbivaccines.com/investors